Skip to content
healthcare.dev

Pyridostigmine Bromide

NDC 69238-1731, Pyridostigmine Bromide, solution, from Amneal Pharmaceuticals NY LLC.

Product NDC
69238-1731
Status
Listed
Labeler
Amneal Pharmaceuticals NY LLC
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212702
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1731 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PYRIDOSTIGMINE BROMIDE60 mg/5mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
69238-1731-269238173102473 mL in 1 BOTTLE (69238-1731-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9c3a5abf-e217-4292-a305-5afd12b99e95
  • NADAC price for package 69238173102

    GET /v1/drugs/nadac/69238173102

Use it

Look up 69238-1731 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1731 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69238-1731. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.